What are we looking for?
Digital Biomarkers in the seven research areas
- Cognition and attention
- Depression and mood
- Digital imaging of skin
Who is eligible for this challenge?
Companies, start-ups, and academic research groups with the state-of-art technology in the above mentioned research areas are all welcome to apply!
What could you expect?
A collaboration opportunity with a global Pharma research team. Budgets is available in advanced stages.
- Step 1: The primary screening will be conducted jointly by ETBA and Novartis Taiwan.
- Step 2: The initial assessment will be executed by the Novartis Institutes for BioMedical Research (NIBR), including workshops and device evaluation.
- Step 3: For promising solutions, formal collaboration will be established and the solution will be deployed in Novartis clinical studies.
November 30, 2020, at 11:00 CET / 18:00 TPE time
To learn more: